Dr. Marios Giannakis at the Dana-Farber Cancer Institute (with co-affiliation at the Broad Institute of MIT and Harvard) is seeking a highly motivated, exceptional candidate to join his laboratory towards obtaining novel insights for the molecular epidemiology, treatment and associated response and resistance of colorectal cancer through the computational analysis of large-scale datasets including whole-exome, whole-transcriptome and single-cell RNA sequencing data. The successful candidate will lead and assist in projects integrating molecular, pathologic and clinical data as well as collaborate with a diverse array of community members both at the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. This individual will work towards analyzing some of the world’s most comprehensive and well-annotated biomedical datasets using novel and established computational approaches towards tackling several of the most pressing questions in cancer biology today. Consequently, there is unparalleled potential for your contributions to be published, used and recognized worldwide.
At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.